• / Free eNewsletters & Magazine
  • / My Account

NASDAQ

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. CEVA, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    CEVA, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  2. Sohu.com to Report Second Quarter 2014 Financial Results on July 28, 2014

    Sohu.com to Report Second Quarter 2014 Financial Results on July 28, 2014

  3. Changyou.com to Report Second Quarter 2014 Financial Results on July 28, 2014

    Changyou.com to Report Second Quarter 2014 Financial Results on July 28, 2014

  4. UPDATE: 2,000 days of Obama: How have stocks done?

    UPDATE: 2,000 days of Obama: How have stocks done?

  5. UPDATE: 2,000 days of Obama: How have stocks done?

    UPDATE: 2,000 days of Obama: How have stocks done?

  6. VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman

    VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman

  7. First Financial Bank Announces New Location in New Waverly

    First Financial Bank Announces New Location in New Waverly

  8. MARKET SNAPSHOT: U.S. Stocks: Futures Rebound Ahead Of Wells Fargo Results

    MARKET SNAPSHOT: U.S. Stocks: Futures Rebound Ahead Of Wells Fargo Results

  9. Rentrak Announces Worldwide Box Office Results for Weekend of July 13, 2014

    Rentrak Announces Worldwide Box Office Results for Weekend of July 13, 2014

  10. Exelixis Announces Positive Top-Line Results for Phase 3 Pivotal Trial of Cobimetinib in Combination With Vemurafenib in Patients With BRAF V600 Mutation-Positive Advanced Melanoma

    Exelixis Announces Positive Top-Line Results for Phase 3 Pivotal Trial of Cobimetinib in Combination With Vemurafenib in Patients With BRAF V600 Mutation-Positive Advanced Melanoma

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.